Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Polymyxin b manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

polymyxin b

Vials, injection 500 000 Units USP/5ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Vietnam
Manufacturer #11531
This pharmaceutical company has been operating since 1970, gaining recognition for its innovative and high-quality pharmaceutical and herbal products, including a wide range of APIs. They specialize in lyophilized injections, with a fully automated production facility capable of producing antibiotics, antifungals, cardiac medications, infertility treatments, antivirals, and proton-pump inhibitors. Their extensive product portfolio is distributed to major hospital chains and medical facilities across the region. The company boasts a strong R&D team focused on developing new products and improving existing ones. They have a global presence with operations spanning multiple regions including North America and the EU. Their focus on lyophilized injections suggests a specialization in this particular dosage form for diverse therapeutic applications.

Manufacturer usually replies in 19 days

polymyxin b

Solution for injection 500000 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Manufacturer usually replies in 19 days

neomycin + polymyxin b + bacitracin

Cutaneous powder 3400 IU + 5000 IU + 400 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #38728

Established in 2012, this Manufacturer is a CTD dossier owner and manufacturer and GMP manufacturer with products sold in over 39 countries across four continents. With multiple WHO-GMP and other regulatory approvals (e.g., Ghana FDA, Philippines FDA, Kenya PBB, Tanzania TFDA, Nigeria NAFDAC), it operates several finished dosage and R&D production lines (tablets, capsules, injectables, liquids, softgels, effervescent, suppositories). As a CTD dossier owner and manufacturer, it supports regulatory filings worldwide. Headquartered in India and employing a global workforce, it serves diverse markets as a CTD dossier owner and manufacturer and GMP manufacturer.

Manufacturer usually replies in 16 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Polymyxin B is an antibiotic used to treat bacterial infections, such as meningitis, pneumonia, sepsis. Although manufacturing companies use polymyxin B as a standalone drug, it is more commonly used in combination drug formulations, along with other active ingredients such as lidocaine, neomycin, bacitracin, diperodon, hydrocortisone, as well as many others. Polymyxin B suppliers market the standalone medication in the form of powders for injectable solutions. In medical use for over 50 years, polymyxin B has since become included in the WHO’s list of Essential Medicines that contains the most important drugs recommended for a basic health system. Polymyxin B suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified polymyxin B manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.